Dublin, Sept. 11, 2023 (GLOBE NEWSWIRE) -- The "The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition" report has been added to ResearchAndMarkets.com's offering.
The 16th edition of "The Worldwide Market for In Vitro Diagnostic Tests" provides a comprehensive analysis of the IVD industry, offering readers insights into market sizing, forecasting, and trends across various segments of the IVD market. With over 1500 pages, this report covers vendor reporting, interviews, and activities on a global scale, making it a must-have resource for those interested or involved in the IVD industry.
Market Segmentation and Coverage
The report offers a comprehensive overview of the IVD market, breaking down different test categories into individual chapters with sub-segments. This approach provides insights into various aspects of the IVD industry, effectively encapsulating multiple market research reports within one.
Highlights and Importance
For over two decades, this report has been an industry staple, offering complete coverage of the IVD sector. It serves as a valuable guide for understanding the current state and future prospects of the IVD market. The 16th edition continues this tradition by providing reliable estimates, forecasts, and insights needed to comprehend the IVD market holistically.
Market Coverage and Analysis
The report covers key IVD market research sections with estimates and forecasts for various test segments, including Clinical Chemistry, Hematology, Histology, Molecular, Immunoassay, Infectious Disease, Coagulation, Blood Bank IVD, and Point of Care. The assessment is based on vendor reporting, interviews, activities, financial filings, and other sources. It also provides information on market size, growth rates, and future projections, along with compound annual growth rates and significant IVD companies operating in the market.
Value Proposition and Relevance
"The Worldwide Market for In Vitro Diagnostic Tests" offers unmatched value by providing a comprehensive overview of the IVD industry, covering all significant test categories, world markets, and regional dynamics. It includes profiles of over 300 companies in the market, offering insights into the top 40 companies. Additionally, the report is a valuable resource for understanding IVD market changes, competitive landscape, investment opportunities, and growth markets across various countries.
Country-Level Coverage
The IVD market is global in nature, and this report reflects the international scope of the industry. The 16th edition provides IVD market size for major world countries and segments. With the influence of trends and developments in one part of the world affecting manufacturers' decisions and financial performance in other regions, the report offers a comprehensive view of the global IVD market.
Competitive Analysis and Corporate Profiling
A significant portion of the report is dedicated to profiling companies in the IVD market, categorizing them into tiers based on their significance. With profiles of over 200 companies, the report offers insights into financial results, product launches, company history, and strategic plans of these companies.
Company Profiles:
- Abbott Diagnostics
- Agilent Technologies
- Beckman Coulter, Inc. / Danaher
- Becton, Dickinson and Company (BD)
- bioMérieux Inc.
- Bio-Rad Laboratories, Inc.
- Bruker Corporation
- Cepheid / Danaher
- Danaher Corporation
- DiaSorin S.p.A
- Grifols S.A.
- Hologic, Inc.
- Instrumentation Laboratory (IL) / Werfen
- Leica Biosystems / Danaher
- Ortho Clinical Diagnostics (QuidelOrtho)
- PerkinElmer, Inc. (PE)
- QIAGEN
- Quidel Corporation (QuidelOrtho)
- Radiometer A/S / Danaher
- Roche Diagnostics
- Siemens Healthineers (Siemens)
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
- Ventana Medical Systems Inc. / Roche Tissue Diagnostics
- Werfen
- ARKRAY
- GI Genomics (formerly Beijing Genome Institute)
- Cue Health
- Dexcom
- Diagnostica Stago S.A.S.
- Eiken Chemical Co., Ltd
- Exact Sciences
- Fulgent Genetics, Inc
- Fujirebio Diagnostics, Inc.
- Horizon Discovery Group plc
- Illumina
- Invitae
- Labcorp, Laboratory Corporation of America
- Luminex Corporation (DiaSorin)
- Masimo Corporation
- Medtronic plc
- Meridian Bioscience, Inc.
- Mindray - Shenzhen Mindray Bio-medical Electronics Co., Ltd.
- Natera
- Myriad Genetics, Inc.
- Philips (Royal Philips)
- Quest Diagnostics
- Randox Laboratories Ltd.
- Theradig
- Thermo Fisher Scientific Inc.
- Ventana Medical Systems Inc. / Roche Tissue Diagnostics
- Berry Genomics Co. ltd.
- CooperGenomics (Division of CooperSurgical)
- INEX Innovate
- Oxford Gene Technology
- Sequenom, Inc. (Integrated Genetics)
- Yourgene Health
- 23andMe
- Agendia BV
- Ambry Genetics
- ARUP Laboratories
- Aspira Women’s Health (formerly Vermillion Inc.)
- BioReference Laboratories
- Biotheranostics
- BluePrint Genetics Oy
- Boston Heart Diagnostics
- CareDx, Inc.
- Helomics Corporation
- Mayo Clinic Laboratories
- MDxHealth SA
- OPKO Diagnostics
- Sonic Healthcare
- Veracyte, Inc.
Conclusion
"The Worldwide Market for In Vitro Diagnostic Tests" provides an unparalleled vision of the current IVD industry. It serves as a vital tool for understanding the IVD market's nuances, trends, and future prospects, making it an essential resource for anyone involved in the IVD industry.
For more information about this report visit https://www.researchandmarkets.com/r/ssgogz
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
